KALY — Kali Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$29.41m
- $94.55m
Annual income statement for Kali, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2008 November 30th | 2009 December 31st | 2010 December 31st | 2011 December 31st | 2012 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 64.3 | 73.8 | 88.8 | 94.5 |
| Cost of Revenue | |||||
| Gross Profit | — | 23.3 | 30 | 38.8 | 42.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 0.066 | 50.8 | 56.5 | 71.1 | 70.4 |
| Operating Profit | -0.066 | 13.6 | 17.3 | 17.7 | 24.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.066 | 14.6 | 19.7 | 18.4 | 24.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.066 | 10.4 | 15 | 13.9 | 17.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.066 | 10.4 | 15 | 13.9 | 17.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.066 | 6.44 | 15 | 13.9 | 17.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.44 | 3.03 | 5.77 | 5.36 | 6.78 |
| Dividends per Share |